Report
US Tariffs' impact on our MedTech coverage - Initial assessment
While not caught off guard, the medtech industry is facing renewed uncertainty following President Trump’s April 2, 2025, announcement of sweeping new import tariffs under the International Emergency Economic Powers Act. Although pharmaceuticals were explicitly exempted—at least for now—medical dev
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Maria Vara
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.